Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-17

Clinical Trial Update: A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

A safety and efficacy trial exploring a treat-and-extend approach with ranibizumab, with or without laser photocoagulation, for diabetic macular edema in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Palmetto Retina Center, LLC | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-17